151 related articles for article (PubMed ID: 11818704)
1. Comparative effect of oral pulse and intravenous calcitriol treatment in hemodialysis patients: the effect on serum IL-1 and IL-6 levels and bone mineral density.
Türk S; Akbulut M; Yildiz A; Gürbilek M; Gönen S; Tombul Z; Yeksan M
Nephron; 2002 Feb; 90(2):188-94. PubMed ID: 11818704
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy of oral and intravenous calcitriol treatment in haemodialysis patients: effects on serum biochemistry and cytokine levels.
Borazan A; Ustün H; Cefle A; Sekitmez N; Yilmaz A
J Int Med Res; 2003; 31(6):489-96. PubMed ID: 14708413
[TBL] [Abstract][Full Text] [Related]
3. Effects of calcitriol on type 5b tartrate-resistant acid phosphatase and interleukin-6 in secondary hyperparathyroidism.
Lu KC; Tseng CF; Wu CC; Yeung LK; Chen JS; Chao TY; Janckila AJ; Yam LT; Chu P
Blood Purif; 2006; 24(5-6):423-30. PubMed ID: 16888370
[TBL] [Abstract][Full Text] [Related]
4. [Oral calcitriol pulse therapy in hemodialysis patients. Effects on histomorphometry of bone in renal hyperparathyroidism].
Sperschneider H; Humbsch K; Abendroth K
Med Klin (Munich); 1997 Oct; 92(10):597-603. PubMed ID: 9446007
[TBL] [Abstract][Full Text] [Related]
5. No difference in intestinal strontium absorption after oral or IV calcitriol in children with secondary hyperparathyroidism. The European Study Group on Vitamin D in Children with Renal Failure.
Ardissino G; Schmitt CP; Bianchi ML; Daccò V; Claris-Appiani A; Mehls O
Kidney Int; 2000 Sep; 58(3):981-8. PubMed ID: 10972662
[TBL] [Abstract][Full Text] [Related]
6. Pulse oral versus pulse intraperitoneal calcitriol: a comparison of efficacy in the treatment of hyperparathyroidism and renal osteodystrophy in peritoneal dialysis patients.
Gadallah MF; Arora N; Torres C; Ramdeen G; Schaeffer-Pautz A; Moles K
Adv Perit Dial; 2000; 16():303-7. PubMed ID: 11045316
[TBL] [Abstract][Full Text] [Related]
7. Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis.
Greenbaum LA; Grenda R; Qiu P; Restaino I; Wojtak A; Paredes A; Benador N; Melnick JZ; Williams LA; Salusky IB
Pediatr Nephrol; 2005 May; 20(5):622-30. PubMed ID: 15785941
[TBL] [Abstract][Full Text] [Related]
8. Twice versus thrice weekly administration of intravenous calcitriol in dialysis patients: a randomized prospective trial. Gruppo Italiano di Studio dell'Osteodistrofia Renale.
Gallieni M; Brancaccio D; Antonucci F; Bellinghieri G; Carpani P; Cozzolino M; D'Agostino F; Del Mastro G; Mallamace A; Memoli B
Clin Nephrol; 2000 Mar; 53(3):188-93. PubMed ID: 10749297
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy of an oral calcitriol pulse or intravenous 22-oxacalcitriol therapies in chronic hemodialysis patients.
Tamura S; Ueki K; Mashimo K; Tsukada Y; Naitoh M; Abe Y; Kawai H; Tsuchida A; Wakamatsu R; Nojima Y
Clin Exp Nephrol; 2005 Sep; 9(3):238-43. PubMed ID: 16189633
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and efficacy of pulse oral versus intravenous calcitriol in hemodialysis patients.
Levine BS; Song M
J Am Soc Nephrol; 1996 Mar; 7(3):488-96. PubMed ID: 8704116
[TBL] [Abstract][Full Text] [Related]
11. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism.
Park CW; Oh YS; Shin YS; Kim CM; Kim YS; Kim SY; Choi EJ; Chang YS; Bang BK
Am J Kidney Dis; 1999 Jan; 33(1):73-81. PubMed ID: 9915270
[TBL] [Abstract][Full Text] [Related]
12. 25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy.
Coen G; Mantella D; Manni M; Balducci A; Nofroni I; Sardella D; Ballanti P; Bonucci E
Kidney Int; 2005 Oct; 68(4):1840-8. PubMed ID: 16164662
[TBL] [Abstract][Full Text] [Related]
13. Effective treatment of secondary hyperparathyroidism in hemodialysis patients by titration of intravenous calcitriol dosage.
Grekas D; Balaskas E; Kampouris H; Benos A; Konstantinou A; Sioullis A; Tourkantonis A
Clin Nephrol; 1999 Sep; 52(3):167-71. PubMed ID: 10499312
[TBL] [Abstract][Full Text] [Related]
14. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure.
Andress DL; Norris KC; Coburn JW; Slatopolsky EA; Sherrard DJ
N Engl J Med; 1989 Aug; 321(5):274-9. PubMed ID: 2631697
[TBL] [Abstract][Full Text] [Related]
15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
16. Beneficial role of intravenous calcitriol on bone mineral density in children with severe secondary hyperparathyroidism.
Baskin E; Ozen S; Karçaaltincaba M; Besbas N; Saatci U; Düzova A; Agras PI; Haliloglu M; Bakkaloglu A
Int Urol Nephrol; 2004; 36(1):113-8. PubMed ID: 15338687
[TBL] [Abstract][Full Text] [Related]
17. Predicting the effect of intravenous calcitriol on parathyroid gland activity using double-phase technetium Tc 99m-sestamibi scintigraphy.
Torregrosa JV; Fuster D; Ybarra J; Ortín J; Moreno A; Valveny N
Am J Kidney Dis; 2004 Sep; 44(3):476-80. PubMed ID: 15332220
[TBL] [Abstract][Full Text] [Related]
18. Elderly patients on chronic hemodialysis with hyperparathyroidism: increase of hemoglobin level after intravenous calcitriol.
Neves PL; Triviño J; Casaubon F; Santos V; Mendes P; Romão P; Bexiga I; Bernardo I
Int Urol Nephrol; 2006; 38(1):175-7. PubMed ID: 16502078
[TBL] [Abstract][Full Text] [Related]
19. Intravenous versus oral calcitriol therapy in renal osteodystrophy: results of a prospective, pulsed and dose-comparable study.
Mazzaferro S; Pasquali M; Ballanti P; Bonucci E; Di Sanza P; Sardella D; Taggi F; Coen G
Miner Electrolyte Metab; 1994; 20(3):122-9. PubMed ID: 7816000
[TBL] [Abstract][Full Text] [Related]
20. Effects of pamidronate and calcitriol on the set point of the parathyroid gland in postmenopausal hemodialysis patients with secondary hyperparathyroidism.
Huang CY; Zheng CM; Wu CC; Lo L; Lu KC; Chu P
Nephron Clin Pract; 2012; 122(3-4):93-101. PubMed ID: 23635416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
